Presentations

FACTORES DE RIESGO CARDIOVASCULARES NO VALORADOS EN LA MUJER

solaci
solaci
549
0

11_maria_paniagua
By: María Paniagua MD FACC FESC
Vice Presidente
Sociedad Interamericana de Cardiología

Previous article
Manejo del Shock Cardiogénico de origen Isquémico
Next article
Angioplastía en Tronco coronario izquierdo y Enfermedad de Múltiples Vasos. Nuevas evidencias 2015.
solaci
solaci

More articles by this author

Recambio valvular aórtico tradicional: PARTNER 5 anos

solaci - 0
By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil

Estenosis aórtica severa con bajo flujo, bajo gradiente y disfunción sistólica

solaci - 0
By: Rubén G. Servián C. MD Departamento de Imágenes – Hospital Central Instituto de Previsión Social (I.P.S.)

Prevención de la enfermedad cardiovascular y ejercicio físico en el adulto: ¿ una cuestión de intensidad?

solaci - 0
By: Dra. María Carolina Acosta Cazal

Angioplastía en Tronco coronario izquierdo y Enfermedad de Múltiples Vasos. Nuevas evidencias 2015.

solaci - 0
By: Dr. Marcelo Halac Hospital Italiano - Buenos Aires

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Recambio valvular aórtico tradicional: PARTNER 5 anos

By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil
solaci -
SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

Dr. Omar Tupayachi - 0
The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Dr. Omar Tupayachi - 0
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Dr. Omar Tupayachi - 0
Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...